The demand for IVD product due to the Covid-19 pandemic is expected to increase mainly due to factors as a sharp rise in market demand for PCR, NGS products, the supportive regulatory landscape for product development & commercialization, and a sharp rise in target patient population. The Chinese market is expected to reach almost 200 billion USD
China, the world’s largest emitter of carbon dioxide, has promised to become carbon neutral before 2060, and to begin cutting its emissions within the next ten years. Such ambitious carbon reduction targets requires immediate action from the Chinese government, presenting new opportunities for players in the carbon neutrality industry.
This report illustrates China digital healthcare landscape: Medical services, Health insurance, Medical Ecommerce, Health management, Healthcare technology upgrade 5 parts.
The Coronavirus Covid-19 has been sweeping the world since the end of 2019. The supply chain industry connected to the global economy has been greatly affected. However, the epidemic also brings different levels of opportunities and challenges to different industries. It is expected to accelerate the implementation of artificial intelligence scenarios and promote the development of unmanned factories and smart factories. Meanwhile for the epidemic situation and medical health, there will be more subdivided AI scenarios to land. The innovations in interdisciplinary fields such as medical, emotional, social, and artificial intelligence will create a new series of products and applications.
The virus is spreading at a slower pace in China, the impact of the “epidemic” on various industries has become the focus of attention. This article sorts out the impact of the epidemic on the medical device industry esp. to the Chinese market.